By NCT Consultants
The NCT APAC 2025 symposium on chemical, biological, radiological, nuclear, and explosive (CBRNe) threats concluded on December 4th at the Lotte World Hotel in Seoul. As the Asia-Pacific region’s largest conference on CBRNe and...
By SERB
One year into her role, SERB Pharmaceuticals CEO Vanessa Wolfeler reflects on the strategic acquisition of RSDL® and the company’s growing leadership in global Medical Countermeasures and CBRN preparedness.
In May 2024, SERB Pharmaceuticals marked an exciting leadership milestone with the appointment of Vanessa...
